Copyright Reports & Markets. All rights reserved.

Global Gabapentin Enacarbil Sales Market Report 2021

Request for Sample of this report
Buy now

1 Gabapentin Enacarbil Market Overview

  • 1.1 Gabapentin Enacarbil Product Scope
  • 1.2 Gabapentin Enacarbil Segment by Type
    • 1.2.1 Global Gabapentin Enacarbil Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Capsule
    • 1.2.3 Tablet
  • 1.3 Gabapentin Enacarbil Segment by Application
    • 1.3.1 Global Gabapentin Enacarbil Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Post-Herpetic Neuralgia (PHN)
    • 1.3.3 Restless Legs Syndrome (RLS)
    • 1.3.4 Others
  • 1.4 Gabapentin Enacarbil Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Gabapentin Enacarbil Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Gabapentin Enacarbil Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Gabapentin Enacarbil Price Trends (2016-2027)

2 Gabapentin Enacarbil Estimates and Forecasts by Region

  • 2.1 Global Gabapentin Enacarbil Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Gabapentin Enacarbil Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Gabapentin Enacarbil Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Gabapentin Enacarbil Revenue Market Share by Region (2016-2021)
  • 2.3 Global Gabapentin Enacarbil Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Gabapentin Enacarbil Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Gabapentin Enacarbil Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Gabapentin Enacarbil Estimates and Projections (2016-2027)
    • 2.4.2 Europe Gabapentin Enacarbil Estimates and Projections (2016-2027)
    • 2.4.3 China Gabapentin Enacarbil Estimates and Projections (2016-2027)
    • 2.4.4 Japan Gabapentin Enacarbil Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Gabapentin Enacarbil Estimates and Projections (2016-2027)
    • 2.4.6 India Gabapentin Enacarbil Estimates and Projections (2016-2027)

3 Global Gabapentin Enacarbil Competition Landscape by Players

  • 3.1 Global Top Gabapentin Enacarbil Players by Sales (2016-2021)
  • 3.2 Global Top Gabapentin Enacarbil Players by Revenue (2016-2021)
  • 3.3 Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2020)
  • 3.4 Global Gabapentin Enacarbil Average Price by Company (2016-2021)
  • 3.5 Manufacturers Gabapentin Enacarbil Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Gabapentin Enacarbil Market Size by Type

  • 4.1 Global Gabapentin Enacarbil Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Gabapentin Enacarbil Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Gabapentin Enacarbil Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Gabapentin Enacarbil Price by Type (2016-2021)
  • 4.2 Global Gabapentin Enacarbil Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Gabapentin Enacarbil Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Gabapentin Enacarbil Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Gabapentin Enacarbil Price Forecast by Type (2022-2027)

5 Global Gabapentin Enacarbil Market Size by Application

  • 5.1 Global Gabapentin Enacarbil Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Gabapentin Enacarbil Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Gabapentin Enacarbil Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Gabapentin Enacarbil Price by Application (2016-2021)
  • 5.2 Global Gabapentin Enacarbil Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Gabapentin Enacarbil Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Gabapentin Enacarbil Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Gabapentin Enacarbil Price Forecast by Application (2022-2027)

6 North America Gabapentin Enacarbil Market Facts & Figures

  • 6.1 North America Gabapentin Enacarbil Sales by Company
    • 6.1.1 North America Gabapentin Enacarbil Sales by Company (2016-2021)
    • 6.1.2 North America Gabapentin Enacarbil Revenue by Company (2016-2021)
  • 6.2 North America Gabapentin Enacarbil Sales Breakdown by Type
    • 6.2.1 North America Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
  • 6.3 North America Gabapentin Enacarbil Sales Breakdown by Application
    • 6.3.1 North America Gabapentin Enacarbil Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Gabapentin Enacarbil Sales Breakdown by Application (2022-2027)

7 Europe Gabapentin Enacarbil Market Facts & Figures

  • 7.1 Europe Gabapentin Enacarbil Sales by Company
    • 7.1.1 Europe Gabapentin Enacarbil Sales by Company (2016-2021)
    • 7.1.2 Europe Gabapentin Enacarbil Revenue by Company (2016-2021)
  • 7.2 Europe Gabapentin Enacarbil Sales Breakdown by Type
    • 7.2.1 Europe Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Gabapentin Enacarbil Sales Breakdown by Application
    • 7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Gabapentin Enacarbil Market Facts & Figures

  • 8.1 China Gabapentin Enacarbil Sales by Company
    • 8.1.1 China Gabapentin Enacarbil Sales by Company (2016-2021)
    • 8.1.2 China Gabapentin Enacarbil Revenue by Company (2016-2021)
  • 8.2 China Gabapentin Enacarbil Sales Breakdown by Type
    • 8.2.1 China Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
  • 8.3 China Gabapentin Enacarbil Sales Breakdown by Application
    • 8.3.1 China 312 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Gabapentin Enacarbil Market Facts & Figures

  • 9.1 Japan Gabapentin Enacarbil Sales by Company
    • 9.1.1 Japan Gabapentin Enacarbil Sales by Company (2016-2021)
    • 9.1.2 Japan Gabapentin Enacarbil Revenue by Company (2016-2021)
  • 9.2 Japan Gabapentin Enacarbil Sales Breakdown by Type
    • 9.2.1 Japan Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Gabapentin Enacarbil Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Gabapentin Enacarbil Market Facts & Figures

  • 10.1 Southeast Asia Gabapentin Enacarbil Sales by Company
    • 10.1.1 Southeast Asia Gabapentin Enacarbil Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Gabapentin Enacarbil Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Gabapentin Enacarbil Sales Breakdown by Type
    • 10.2.1 Southeast Asia Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Gabapentin Enacarbil Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Gabapentin Enacarbil Market Facts & Figures

  • 11.1 India Gabapentin Enacarbil Sales by Company
    • 11.1.1 India Gabapentin Enacarbil Sales by Company (2016-2021)
    • 11.1.2 India Gabapentin Enacarbil Revenue by Company (2016-2021)
  • 11.2 India Gabapentin Enacarbil Sales Breakdown by Type
    • 11.2.1 India Gabapentin Enacarbil Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Gabapentin Enacarbil Sales Breakdown by Type (2022-2027)
  • 11.3 India Gabapentin Enacarbil Sales Breakdown by Application
    • 11.3.1 India Gabapentin Enacarbil Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Gabapentin Enacarbil Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Gabapentin Enacarbil Business

  • 12.1 Arbor Pharma
    • 12.1.1 Arbor Pharma Corporation Information
    • 12.1.2 Arbor Pharma Business Overview
    • 12.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Arbor Pharma Gabapentin Enacarbil Products Offered
    • 12.1.5 Arbor Pharma Recent Development
  • 12.2 Astellas
    • 12.2.1 Astellas Corporation Information
    • 12.2.2 Astellas Business Overview
    • 12.2.3 Astellas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Astellas Gabapentin Enacarbil Products Offered
    • 12.2.5 Astellas Recent Development
  • 12.3 GlaxoSmithKline
    • 12.3.1 GlaxoSmithKline Corporation Information
    • 12.3.2 GlaxoSmithKline Business Overview
    • 12.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 GlaxoSmithKline Gabapentin Enacarbil Products Offered
    • 12.3.5 GlaxoSmithKline Recent Development
  • 12.4 Glenmark Pharma
    • 12.4.1 Glenmark Pharma Corporation Information
    • 12.4.2 Glenmark Pharma Business Overview
    • 12.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Glenmark Pharma Gabapentin Enacarbil Products Offered
    • 12.4.5 Glenmark Pharma Recent Development
  • 12.5 Pfizer
    • 12.5.1 Pfizer Corporation Information
    • 12.5.2 Pfizer Business Overview
    • 12.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Pfizer Gabapentin Enacarbil Products Offered
    • 12.5.5 Pfizer Recent Development
  • 12.6 Depomed
    • 12.6.1 Depomed Corporation Information
    • 12.6.2 Depomed Business Overview
    • 12.6.3 Depomed Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Depomed Gabapentin Enacarbil Products Offered
    • 12.6.5 Depomed Recent Development
  • 12.7 Teva
    • 12.7.1 Teva Corporation Information
    • 12.7.2 Teva Business Overview
    • 12.7.3 Teva Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Teva Gabapentin Enacarbil Products Offered
    • 12.7.5 Teva Recent Development
  • 12.8 Mylan
    • 12.8.1 Mylan Corporation Information
    • 12.8.2 Mylan Business Overview
    • 12.8.3 Mylan Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Mylan Gabapentin Enacarbil Products Offered
    • 12.8.5 Mylan Recent Development
  • 12.9 Novartis
    • 12.9.1 Novartis Corporation Information
    • 12.9.2 Novartis Business Overview
    • 12.9.3 Novartis Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Novartis Gabapentin Enacarbil Products Offered
    • 12.9.5 Novartis Recent Development
  • 12.10 Apotex
    • 12.10.1 Apotex Corporation Information
    • 12.10.2 Apotex Business Overview
    • 12.10.3 Apotex Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Apotex Gabapentin Enacarbil Products Offered
    • 12.10.5 Apotex Recent Development
  • 12.11 Sun Pharmaceutical
    • 12.11.1 Sun Pharmaceutical Corporation Information
    • 12.11.2 Sun Pharmaceutical Business Overview
    • 12.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Sun Pharmaceutical Gabapentin Enacarbil Products Offered
    • 12.11.5 Sun Pharmaceutical Recent Development
  • 12.12 Aurobindo Pharma
    • 12.12.1 Aurobindo Pharma Corporation Information
    • 12.12.2 Aurobindo Pharma Business Overview
    • 12.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Aurobindo Pharma Gabapentin Enacarbil Products Offered
    • 12.12.5 Aurobindo Pharma Recent Development
  • 12.13 Intas
    • 12.13.1 Intas Corporation Information
    • 12.13.2 Intas Business Overview
    • 12.13.3 Intas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Intas Gabapentin Enacarbil Products Offered
    • 12.13.5 Intas Recent Development
  • 12.14 Amneal
    • 12.14.1 Amneal Corporation Information
    • 12.14.2 Amneal Business Overview
    • 12.14.3 Amneal Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Amneal Gabapentin Enacarbil Products Offered
    • 12.14.5 Amneal Recent Development
  • 12.15 Marksans Pharma
    • 12.15.1 Marksans Pharma Corporation Information
    • 12.15.2 Marksans Pharma Business Overview
    • 12.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Marksans Pharma Gabapentin Enacarbil Products Offered
    • 12.15.5 Marksans Pharma Recent Development
  • 12.16 Alkem
    • 12.16.1 Alkem Corporation Information
    • 12.16.2 Alkem Business Overview
    • 12.16.3 Alkem Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Alkem Gabapentin Enacarbil Products Offered
    • 12.16.5 Alkem Recent Development
  • 12.17 Jiangsu Enhua
    • 12.17.1 Jiangsu Enhua Corporation Information
    • 12.17.2 Jiangsu Enhua Business Overview
    • 12.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Jiangsu Enhua Gabapentin Enacarbil Products Offered
    • 12.17.5 Jiangsu Enhua Recent Development
  • 12.18 Jiangsu Hengrui
    • 12.18.1 Jiangsu Hengrui Corporation Information
    • 12.18.2 Jiangsu Hengrui Business Overview
    • 12.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Jiangsu Hengrui Gabapentin Enacarbil Products Offered
    • 12.18.5 Jiangsu Hengrui Recent Development
  • 12.19 Sailike Pharma
    • 12.19.1 Sailike Pharma Corporation Information
    • 12.19.2 Sailike Pharma Business Overview
    • 12.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Sailike Pharma Gabapentin Enacarbil Products Offered
    • 12.19.5 Sailike Pharma Recent Development

13 Gabapentin Enacarbil Manufacturing Cost Analysis

  • 13.1 Gabapentin Enacarbil Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Gabapentin Enacarbil
  • 13.4 Gabapentin Enacarbil Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Gabapentin Enacarbil Distributors List
  • 14.3 Gabapentin Enacarbil Customers

15 Market Dynamics

  • 15.1 Gabapentin Enacarbil Market Trends
  • 15.2 Gabapentin Enacarbil Drivers
  • 15.3 Gabapentin Enacarbil Market Challenges
  • 15.4 Gabapentin Enacarbil Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Gabapentin Enacarbil market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gabapentin Enacarbil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Capsule
    Tablet

    Segment by Application
    Post-Herpetic Neuralgia (PHN)
    Restless Legs Syndrome (RLS)
    Others

    The Gabapentin Enacarbil market is analysed and market size information is provided by regions (countries). Segment by Application, the Gabapentin Enacarbil market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Arbor Pharma
    Astellas
    GlaxoSmithKline
    Glenmark Pharma
    Pfizer
    Depomed
    Teva
    Mylan
    Novartis
    Apotex
    Sun Pharmaceutical
    Aurobindo Pharma
    Intas
    Amneal
    Marksans Pharma
    Alkem
    Jiangsu Enhua
    Jiangsu Hengrui
    Sailike Pharma

    Buy now